0.02
+0(+0.00%)
Currency In USD
| Previous Close | 0.02 |
| Open | 0.02 |
| Day High | 0.02 |
| Day Low | 0.02 |
| 52-Week High | 0.06 |
| 52-Week Low | 0.02 |
| Volume | 4,013 |
| Average Volume | 143,576 |
| Market Cap | 1.81M |
| PE | -0.13 |
| EPS | -0.19 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.03 |
| Change | 0 |
If you invested $1000 in Galera Therapeutics, Inc. (GRTX) since IPO date, it would be worth $2 as of November 13, 2025 at a share price of $0.024. Whereas If you bought $1000 worth of Galera Therapeutics, Inc. (GRTX) shares 5 years ago, it would be worth $2.35 as of November 13, 2025 at a share price of $0.024.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
GlobeNewswire Inc.
Oct 22, 2025 11:00 AM GMT
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 mill
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
GlobeNewswire Inc.
Dec 31, 2024 12:00 PM GMT
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is Phase 1/2 trial of Nova Pharmaceutical’s Clinical Stage N